Navigation Links
AEterna Zentaris and Paladin Labs Announce Sale and Purchase of Miltefosine Rights
Date:3/3/2008

QUEBEC CITY and MONTREAL, March 3 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS;TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and oncology, and Paladin Labs Inc. (TSX: PLB), a leading Canadian specialty pharmaceutical company, announced today that they have entered into a definitive purchase and sale agreement with respect to all rights related to the manufacture, production, distribution, marketing, sale and/or use of miltefosine for an aggregate purchase price of Cdn$9.125 million payable in cash, subject to certain post-closing purchase price adjustments. Miltefosine, sold under the brand name Impavido(R) throughout the world, recorded revenues of Euro 2.5 million in 2007. Completion of the transactions contemplated by the purchase agreement is subject to customary closing conditions, including the parties having received certain third-party consents and approvals.

David J. Mazzo, Ph.D., President and CEO of AEterna Zentaris commented, "Last fall, we put forth our new focused business strategy which included identifying non-core assets and actively seeking to divest them as a way to infuse non-dilutive funds into the Company. We are very pleased to have entered into an agreement for the sale of the compound, miltefosine, and look forward to consummating the deal in the near future."

"This transaction marks the first time that Paladin has acquired international rights to a patented, medically important product", said Jonathan Ross Goodman, President and CEO of Paladin Labs. "This transaction is expected to be immediately accretive to earnings and it fits within our broader strategy to grow Paladin's revenues beyond the Canadian border."

About miltefosine

Miltefosine
'/>"/>

SOURCE AETERNA ZENTARIS INC.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. AEterna Zentaris Announces the Departure of SVP, Administrative and Legal Affairs
2. Aeterna Zentaris to Announce Fourth Quarter and Full-Year 2007 Financial and Operating Results on March 5, 2008
3. AEterna Zentaris to Present at the Upcoming Roth Capital Partners 20th Annual OC Growth Stock Conference in Dana Point, California
4. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
5. AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment
6. AEterna Zentaris Announces Outcome of Managements Strategic Review
7. AEterna Zentaris to Present at Upcoming UBS Global Life Sciences Conference in New York
8. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
9. BioWa Announces Expansion of License Agreement with Genentech for BioWas POTELLIGENT(R) Technology
10. DW Healthcare Partners Announces the Sale of Tandem Labs
11. MiddleBrook Pharmaceuticals to Announce Fourth Quarter and Full Year 2007 Financial Results on March 4, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...hed the Sixth Milestone in its Ofatumumab ...N, Denmark, October 10 /- G...d the sixth milestone for,ofatumumab (HuMax-CD20(R...SmithKline (GSK). A milestone payment of approxima...) was triggered by the first patient,receiving tre...
(Date:10/10/2008)...Oct. 10 /Xinhua-- Beike,Biotechnology...bal leader in,stem cell research and treatment thr...as signed eight separate mutual cooperation agreem...anding stem cell research organizations.,As part o...em Cell Expert,Advisory Committee" and a separate ...
(Date:10/10/2008)...RNewswire/ -- Twenty of Britain,s most,innovative ...bit their,ideas at the fifth annual SETsquared Par...eld at One Great George Street, London, from 8am o...m of technology innovators,in electronics, informa...Six companies will give 10-minute presentations to...
(Date:10/10/2008)...Newswire/ -- Takeda Pharmaceutical Company,Limited...earch and,Development Center, Inc., a wholly owned...ation that the U.S. Food and Drug Administration (...e alogliptin New Drug Application,(NDA) by the Pre...r 27,2008., "In our most recent discussion with ...
Breaking Biology Technology:Genmab Reaches Milestone in Ofatumumab Collaboration 2Stem Cell Leader Beike Signs 8 New Cooperation Agreements, Establishes Safety Monitoring Boards 2Stem Cell Leader Beike Signs 8 New Cooperation Agreements, Establishes Safety Monitoring Boards 3Creators of Britain's Innovation Economy to Showcase the Technologies of the Future at the Fifth SETsquared Partnership Showcase 2008 2Creators of Britain's Innovation Economy to Showcase the Technologies of the Future at the Fifth SETsquared Partnership Showcase 2008 3FDA Continues Review of Takeda's New Drug Application for Alogliptin (SYR-322), a DPP-4 Agent for Type 2 Diabetes 2
...sultant Tom Koulopoulos said at the Fusion2006 CE...identify information technology work they do that ... outside of the organization. As you might expect,...house raises a lot of questions, so WTN followed u...nce in IT and outsourcing. , ,This is part one of ...
Madison, Wis. Berbee Information Networks Corporation said it has been named Cisco Systems, U.S. IP communications partner of the year for 2005. , ,The award recognizes revenue growth and custom
...ht say the legacy of the 2005-2006 session of the ...y or Senate floor, but in court, where a few forme...e resources for campaigns. Others might say this L...y diet of social issues, from carrying concealed w...back the death penalty. , ,There,s a third way to...
..., Wis. The latest in a growing body of sharehold...g software developer dearly. , ,Alleging that memb...ties law, shareholders of Merge Technologies, Inc... management software, have filed several lawsuits ...Merge,s $325 million stock purchase of Cedara Corp...
Other Biology Technology:IT outsourcing according to Tom Koulopoulos, part 1 2IT outsourcing according to Tom Koulopoulos, part 1 3Four ways lawmakers could help Wisconsins high-growth economy 2Four ways lawmakers could help Wisconsins high-growth economy 3Merge's merger is the crux of shareholder lawsuits 2
(Date:10/10/2008)...tigators from the Herman B Wells Center for Pediat...edicine are focusing on a family of blood proteins...ic effects of chemotherapy in children and adults....opment of targeted therapies for leukemia, multipl...researchers, led by Kristin T. Chun, Ph.D., assist...
(Date:10/10/2008)...the 1950s, Austrian and Swiss scientists conducted...taking photographs of the glaciers, mountains and ...ist Fritz Mller spent eight months in the region a...raphing the Himalayan glaciers. , Now, fifty yea... these scientists are of immense value in trying t...
(Date:10/10/2008)...may make us all go a little gooey, but it,s not tu...health researchers at The Australian National Univ... Mental Health Research (CMHR) at ANU suggests th...ffects their cognitive functions, there is no evid...en released as part of Mental Health Week, which r...
(Date:10/9/2008)... conventional wisdom, tropical plant and animal sp...h may be threatened by global warming, according t...t Robert K. Colwell and colleagues in this week,s ...h,s climate has warmed in recent decades, the geog...nd plant species in the US and Europe have moved n...
Breaking Biology News(10 mins):On the trail of a targeted therapy for blood cancers 2'Himalaya -- Changing Landscapes' photo exhibition draws attention to the impacts of climate change 2'Himalaya -- Changing Landscapes' photo exhibition draws attention to the impacts of climate change 3Pregnancy not turning minds to mush: Study 2Tropical rainforest and mountain species may be threatened by global warming 2Emmy 28R 29 and Golden Globe 28R 29 Nominated Actress Marcia Cross to Join Lifetime Networks and Members of Congress From Both Parties at Capitol Hil 2663 1Emmy 28R 29 and Golden Globe 28R 29 Nominated Actress Marcia Cross to Join Lifetime Networks and Members of Congress From Both Parties at Capitol Hil 2663 2Emmy 28R 29 and Golden Globe 28R 29 Nominated Actress Marcia Cross to Join Lifetime Networks and Members of Congress From Both Parties at Capitol Hil 2663 3Mayo Clinic Proceedings January Tip Sheet 1228 1Mayo Clinic Proceedings January Tip Sheet 1228 2Mayo Clinic Proceedings January Tip Sheet 1228 3Molecule May Trigger Psoriasis 9780 1Case researcher in RNA biology makes waves by challenging current thinking 1964 1Case researcher in RNA biology makes waves by challenging current thinking 1964 2
... increasing among the general population in Canada...First Nations, Inuit and Métis children. In a stud...blic Health, University of Alberta researchers fou...northern Quebec communities were overweight or obe... at the University of Alberta, and her colleagues ...
... oldest questions in human physiology, researchers...hy the body,s immune system - perpetually on guard...ttack tissues in the small intestine that harbor m...ruary issue of Nature Immunology, and which is cur...dvanced online publication, investigators led by S...
...ext Generation," Geordi La Forge is a blind charac...implants in his eyes. While the Star Trek characte...e 21st century may not have to wait that long for ...m, a University of Missouri-Columbia veterinary op...mplant to help blind animals "see." According to N...
...ity researchers have discovered men with an unusua... than men the same age who are cognitively normal....A), a neurological disease in which people have tr...eople lose the ability to express themselves and u...r,s disease in which a person,s memory becomes imp...
Other Biology News:Why doesn't the immune system attack the small intestine? 2MU researcher placing eye implants in cats to help humans see 2Vasectomy may put men at risk for type of dementia 2Vasectomy may put men at risk for type of dementia 3
... is the first higher plant to be fully sequenced a...nism for gene expression research in higher plants...he ATH1 v.5 database of The Institute for Genomic ...base at the University of Delaware. Nearly 40,000 ...
... is in solution or in a gel piece, we can identify...s will be digested to produce a mixture of peptide...e determined by MALDI-TOF, and the amino acid sequ...F will be determined by MALDI-TOF/TOF. The masses ...
...interferons are cytopathic effect inhibition assay... types include; tissue culture supernatents; serum...ese assays, one unit is defined as the quantity of...cytopathic effect of viral infection by 50%. All...
supplied with 10x reaction buffer
Biology Products: